drugset / Trial / NCT01149018

Efficacy Trial of Oral Tetrahydrocannabinol in Patients With Fibromyalgia

NCT01149018

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of the study is to evaluate the effectiveness of oral tetrahydrocannabinol in patients suffering from Fibromyalgia

Timeline

Start
2010-06
Primary completion
2012-07
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Dronabinol Other / unclassified 5 mg Oral

Indications